Pronostic Score of Morbidity to Determine Risk of Complications After Endoscopic Submucosal Dissection for Colorectal Lesions
Proof of Concept for the Development of Clinical or Mixed Prognostic Score of Morbidity After Endoscopic Subcostal Dissection for Colorectal Lesions in Nancy's Hospital Since 2016 to Nowadays
1 other identifier
observational
168
1 country
1
Brief Summary
The mains complications in colo-rectal dissection are the pain, the delayed bleeding and the perforation and represent around 10%. Currently, the procedure is realized during a hospitalization with not real recommendation about the time of this. There is currently no score established for the colo-rectal endoscopic submucosal dissection.
- To develop clinical or mixed prognostic score after endoscopic subcostal dissection for colorectal lesions in Nancy's hospital.
- Allow to obtain an estimation of number of patients required for a larger study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 16, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 20, 2020
CompletedFirst Submitted
Initial submission to the registry
November 23, 2020
CompletedFirst Posted
Study publicly available on registry
November 30, 2020
CompletedNovember 30, 2020
November 1, 2020
4.4 years
November 23, 2020
November 27, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To develop clinical or mixed prognostic score after endoscopic subcostal dissection for colorectal lesions in Nancy's hospital.
From 2016 to 2020
Secondary Outcomes (1)
Allow to obtain an estimation of number of patients required for a larger study
From 2016 to 2020
Interventions
endoscopic submucosal dissection
Eligibility Criteria
Patient, more than 18 years old with no contra indication of the general anesthesia suffering of lesion relevant of endoscopic submucosal dissection treatment.
You may qualify if:
- Patient suffering of lesion relevant of endoscopic submucosal dissection treatment:
- Lesions for which en bloc resection with snare EMR is difficult to apply i/LST-NG, particularly LST-NG (PD) ii/ Lesions showing a VI-type pit pattern iii/ Carcinoma with shallow T1 (SM) invasion Large depressed-type tumors iv/ Large protruded-type lesions suspected to be carcinoma
- Mucosal tumors with submucosal fibrosis
- Sporadic tumors in conditions of chronic inflammation such as ulcerative colitis
- Local residual or recurrent early carcinomas after endoscopic resection Local res Les lésions de plus
- Male or female patients aged ≥ 18 years old
- Patients able to fill in questionnaires written in French
You may not qualify if:
- Suspicion of deep submucosal cancer by analysis of macroscopic appearance (Paris O-III), vascular pattern and pit pattern (SANO IIIB, KUDO Vn)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHRU Brabois
Nancy, Meurthe ET Moselle, 54000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jean Baptiste CHEVAUX
Doctor
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 23, 2020
First Posted
November 30, 2020
Study Start
June 16, 2016
Primary Completion
November 20, 2020
Study Completion
November 20, 2020
Last Updated
November 30, 2020
Record last verified: 2020-11